首页 | 本学科首页   官方微博 | 高级检索  
     

温阳宣肺方对哮喘急性发作期患者CXC型趋化因子的影响
引用本文:张玲,王俊峰. 温阳宣肺方对哮喘急性发作期患者CXC型趋化因子的影响[J]. 中国现代医学杂志, 2023, 0(1): 59-64
作者姓名:张玲  王俊峰
作者单位:西南医科大学中西医结合学院(西南医科大学附属中医医院), 四川 泸州 646000
基金项目:国家中医药管理局科研基金项目(No:2019XZZX-LG007)
摘    要:目的 探讨温阳宣肺方对哮喘急性发作期患者CXC型趋化因子的影响。方法 前瞻性选取2019年1月—2020年10月西南医科大学附属中医医院收治的126例哮喘急性发作期患者,根据奇偶数分组法分为两组。对照组给予西药对症治疗;观察组在西药基础上联合温阳宣肺方治疗。比较两组治疗后的临床效果。结果 观察组总有效率高于对照组(P <0.05)。两组治疗前后CXC型趋化因子12(CXCL12)、CXC 型趋化因子 13(CX‐CL13)、T辅助细胞1(Th1)、T 辅助细胞 2(Th2)及 Th1/Th2 的差值比较,差异有统计学意义(P <0.05),观察组优于对照组。两组治疗前后第1秒用力呼气容积占预计值百分比(FEV1%)、第1秒用力呼气容积与用力肺活量比值(FEV1/FVC)及呼气流量峰值(PEF)的差值比较,差异有统计学意义(P <0.05),观察组高于对照组。两组治疗前后喘息、咳嗽、气短、恶寒发热、头疼身痛、渴喜热饮等积分的差值比较,差异有统计学意义(P <0.05),观察组高于对照组。两组在用药期间不良反应比较,差异无...

关 键 词:哮喘急性发作期  温阳宣肺方  CXC型趋化因子  肺功能
收稿时间:2022-06-30

Effect of Wenyang Xuanfei recipe on CXC chemokine in patients with acute exacerbation of asthma
Zhang Ling,Wang Jun-feng. Effect of Wenyang Xuanfei recipe on CXC chemokine in patients with acute exacerbation of asthma[J]. China Journal of Modern Medicine, 2023, 0(1): 59-64
Authors:Zhang Ling  Wang Jun-feng
Affiliation:College of Integrated Ttraditional Chinese and Western Medicine to Southwest Medical University (Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University), Luzhou, Sichuan 646000, China
Abstract:Objective To observe the effect of Wenyang Xuanfei Recipe on CXC chemokine in patients with acute attack of asthma.Methods A total of 126 patients with acute asthma exacerbation in our hospital were prospectively selected and divided into two groups according to the odd-even grouping method. The control group was treated with symptomatic western medicine, the observation group was treated with Wenyang Xuanfei prescription on the basis of western medicine, and the clinical effects of the two groups were compared after treatment.Results The total effective rate in the observation group was higher than that in the control group, with statistical significance (P < 0.05). The ratio of CXCL12, CXCL13, Th1, Th2 cells, and the difference between Th1/Th2 before and after treatment in the two groups were compared by T test, and the differences were statistically significant (P < 0.05). The difference of Th1/Th2 and Th1/Th2 were higher than those of the control group. The differences of FEV1%, FEV1/FVC, and PEF between the two groups before and after treatment were compared, and the T test showed that the differences were statistically significant (P < 0.05). The differences of FEV1%, FEV1/FVC, and PEF in the observation group were higher than those in the control group. Differences in the scores of wheezing, cough, shortness of breath, aversion to cold and fever, headache and body pain, and thirst for hot drinks before and after treatment in the two groups were compared, and the difference was statistically significant by T test (P < 0.05). Shortness of breath, aversion to cold and fever, headache and body pain, and thirst for hot drink scores were higher than those in the control group. There was no statistical significance in the comparison of adverse reactions between the two groups during the treatment period (P > 0.05).Conclusion Wenyang Xuanfei decoction can reduce the expression of CXC chemokine, regulate the imbalance of Th1 / Th2 cells, and improve lung function.
Keywords:asthma, acute exacerbation  Wenyang Xuanfei recipe  chemokines, CXC  lung function
点击此处可从《中国现代医学杂志》浏览原始摘要信息
点击此处可从《中国现代医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号